Pfizer and Medivation Initiate Two Phase 3 Trials of Dimebon
|
04 November 2009 |
Pfizer Reports Third-Quarter 2009 Results
|
22 October 2009 |
Pfizer And Wyeth Become One: Working Together For A Healthier Worldâ¢
|
16 October 2009 |
Pfizer Completes Acquisition Of Wyeth
|
16 October 2009 |
Pfizer Receives Clearance From The U.S. Federal Trade Commission And The Canadian Competition Bureau
|
15 October 2009 |
FDA Advisory Committee Recommends Approval of Pfizer's Selzentry
|
09 October 2009 |
Pfizer and Wyeth to Divest Certain Animal Health Assets to Boehringer Ingelheim
|
22 September 2009 |
Pfizer Concludes Previously Disclosed Settlement Agreement with U.S. Department of Justice
|
02 September 2009 |
New Analysis of the Pfizer-Sponsored TNT Clinical Trial
|
02 September 2009 |
Pfizer And Private Access Announce Plans To Develop Online Community To Accelerate Clinical Research
|
20 August 2009 |
President Clinton, Pfizer, and Mylan Announce New Agreements to Lower Prices of Medicines
|
07 August 2009 |
Pfizer in Partnership with Shanghai Institutes for Biological Sciences for Drug Discovery Activities
|
30 July 2009 |
Pfizer Reports Second-Quarter 2009 Revenues of $11.0 Billion
|
23 July 2009 |
Pfizer Receives Approval From European Commission For Pending Acquisition Of Wyeth
|
18 July 2009 |
Pfizer Announces New Phase 1 Data From Two Novel Compounds For Alzheimer's Disease
|
16 July 2009 |
Graceway Pharmaceuticals Acquires Early-stage Dermatological Molecules from Pfizer
|
03 July 2009 |
Pfizer Discontinues Phase 3 Trial of Sutent® in Metastatic Colorectal Cancer
|
01 July 2009 |
Sutent Significantly Improved Progression-Free Survival
|
26 June 2009 |
Pfizer Expands Its Generics Portfolio
|
22 May 2009 |
Pfizer Launches Free Medicines Program For Newly Unemployed Americans
|
15 May 2009 |